MedTrace Logo

Custom Molded Foot Orthoses Effect on Foot Kinematics and Lower Extremity Electromyography During Walking and Running.

NCT02143947 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2015-05-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study was to determine the effectiveness of two types of in-shoe custom made orthotics in altering the motion of the foot and muscle activity of select muscles of the lower leg in individuals experiencing lower extremity symptoms of a non traumatic origin. We hypothesized that orthotics would decrease the extent of motion of the during walking and running when compared to a barefoot condition. The investigators further hypothesized that orthotics would decrease the amount of muscle activity seen during walking and running when compared to barefoot walking.

Conditions

  • Lower Extremity Pain of a Mechanical Origin

Interventions

DEVICE

Maximal Arch Subtalar Stabilization

Custom made semi-rigid thermoplastic heel cup extending to the base of the metatarsals with a full foot length 3.0mm thick EVA and ultra-suede top cover

DEVICE

Full Contact Orthosis

The Full Contact orthosis is constructed from a 5/32" blue polypropylene with posting material comprised of white polypropylene.

Sponsors & Collaborators

  • Sole Supports, Inc

    collaborator UNKNOWN

  • Quinnipiac University

    lead OTHER

Principal Investigators

  • Juan C Garbalosa, PT, PhD · Quinnipiac University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2009-04-30
Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02143947 on ClinicalTrials.gov